1. Contemporary experience of percutaneous management of complex aortic and ventricular pseudoaneurysms associated to perivalvular leak: A case series and review of literature.
- Author
-
von Buchwald CL, Mohammed M, Shpilsky D, Frisoli T, Lee J, Engel Gonzalez PA, Wang DD, O'Neill B, O'Neill WW, and Villablanca PA
- Subjects
- Humans, Male, Female, Treatment Outcome, Aged, Middle Aged, Heart Aneurysm diagnostic imaging, Heart Aneurysm etiology, Heart Aneurysm therapy, Cardiac Catheterization adverse effects, Aortic Aneurysm diagnostic imaging, Aortic Aneurysm surgery, Time Factors, Aged, 80 and over, Heart Valve Prosthesis, Aortic Valve surgery, Aortic Valve diagnostic imaging, Echocardiography, Transesophageal, Adult, Aneurysm, False diagnostic imaging, Aneurysm, False etiology, Aneurysm, False therapy, Heart Valve Prosthesis Implantation adverse effects, Heart Valve Prosthesis Implantation instrumentation
- Abstract
Background: Percutaneous closure of aortic and ventricular pseudoaneurysms (PSA) has only been reported on a case report and series basis. In previous case reports, percutaneous closure has been performed successfully in patients of prohibitive surgical risk. This case series aims to show feasibility of percutaneous closure of aortic and ventricular pseudoaneurysm secondary to perivalvular leak (PVL) in a small patient population and the utility of multimodality imaging as an integral tool in procedural planning. This is the largest complex case series to date describing the feasibility and success rate of complex PSA closure, with a follow-up period of up to 4 years., Material and Methods: We performed institutional review and systemic literature review to identify all paravalvular leak cases with associated pseudoaneurysm formation for which a closure procedure was performed. Ten patients were identified. Pooled analysis for cases from institutional review (n = 10) and systemic literature review (n = 39) was performed. The success rate was 100 %. At 30-days, the mortality was 0 %., Conclusion: In paravalvular leak patients with subsequent pseudoaneurysm formation, exhaustive imaging evaluation is required for closure. However, it can be achievable with favorable rates of success., Competing Interests: Declaration of competing interest Disclosures: Dr. Wang is a consultant to Edwards Lifesciences, Abbott, Neochord, Boston Scientific, and receives research grant support from Boston Scientific assigned to employer Henry Ford Health System. Dr. Villablanca is a consultant for Edwards Lifesciences, Abiomed, Angiodynamics and Teleflex. Dr. Frisoli is a proctor for Edwards Lifesciences, Abbott, Boston Scientific, and Medtronic. Dr. B O'Neill is a consultant to and receives research support from Edwards Lifesciences. Dr. W O'Neill has served as a consultant for Abiomed, Edwards Lifesciences, Medtronic, Boston Scientific, Abbott Vascular, and St. Jude Medical; and serves on the Board of Directors of Neovasc Inc. All other authors report no relevant financial disclosures., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF